PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
Year: 2022
Type: article
Abstract: Highlights• ABCB1 overexpression significantly desensitized both drug-selected and gene-transfected cells, which overexpress ABCB1, to OTS964 and that this drug resistance can be antagonized by verapamil, a known ABCB1 inhibitor.Consistently, a similar trend was observed in tumor-bearing mice.• OTS964 stimulated ATPase activity of ABCB1 and upregulated expression levels of ABCB1, resulting in induced resistance to other ABCB1 substrate-drugs, such as paclitaxel.• OTS964 received a comparable affinity score and can dock into the substrate-binding site of human ABCB1 protein.
Source: Molecular Cancer
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,690
Awards: G1558563794, G8525334282
OpenAlex ID: W4210825429
